Welcome to our dedicated page for RELIQ HEALTH TECHS news (Ticker: RQHTF), a resource for investors and traders seeking the latest updates and insights on RELIQ HEALTH TECHS stock.
Reliq Health Technologies Inc. (RQHTF) is a leading healthcare technology company focused on developing innovative remote patient monitoring solutions. The company's core business revolves around providing advanced telemedicine platforms and mobile health apps that enable healthcare providers to deliver high-quality care to patients in their homes. With a strong emphasis on improving patient outcomes and reducing healthcare costs, Reliq Health Techs Inc. has established itself as a key player in the digital health industry.
Reliq Health Technologies is excited to announce its participation in Gravitas’ 5th Annual Growth Conference on March 3, 2022, at the Fairmont Pacific Rim Hotel in Vancouver and online. CEO Dr. Lisa Crossley will present at 2:30 PM PST and engage in a panel discussion at 10:00 AM PST. This conference will connect Reliq with potential investors amidst expanding virtual care opportunities, including a new 20 million patients eligible for Remote Therapeutic Monitoring via Medicare.
Reliq Health Technologies Inc. (OTC:RQHTF) has signed implementation agreements expected to onboard over 10,000 new patients this year, leveraging new Medicare Remote Therapeutic Monitoring (RTM) billing codes. These codes, introduced on January 1, 2022, have expanded the eligible patient population by over 20 million, improving revenue opportunities for specialists. The average revenue per patient is estimated at $40 monthly. The company's iUGO Care platform aims to enhance virtual care, reducing hospitalization costs while improving patient outcomes.
Reliq Health Technologies Inc. (OTC:RQHTF) has announced the signing of three contracts with orthopaedic practices in Texas and California, aiming to onboard over 2,000 new patients this year. The company will utilize its iUGO Care platform for Remote Therapeutic Monitoring. With projected revenues exceeding $50 per patient monthly, Reliq is poised to benefit from Medicare's expanded virtual care programs. The new contracts underscore the growing demand for remote monitoring in musculoskeletal care.
Reliq Health Technologies Inc. (OTC:RQHTF) has formed a partnership with Data Soft Logic (DSL) to offer its iUGO Care platform to DSL’s existing and new clients. This alliance targets over 600 home health and hospice agencies in the U.S., which collectively cater to over 500,000 Medicare and Medicaid patients. Reliq anticipates onboarding patients starting Q2 2022, expecting to add over 50,000 new patients annually by 2023, generating estimated revenues of $60 per patient per month.
Reliq Health Technologies Inc. (OTC:RQHTF) announced new contracts with five physician practices across Texas, Puerto Rico, and California, expected to add over 3,000 patients to its platform by the end of Q2 2022. The average revenue per patient is projected to exceed $60 USD per month. Enhanced reimbursement rates from CMS, effective January 1, 2022, include an 8% increase for existing services and new billing codes for Remote Therapeutic Monitoring. This reflects growing market demand for Reliq's iUGO Care platform, aimed at improving patient outcomes and reducing healthcare costs.
Reliq Health Technologies Inc. has formed a strategic agreement with Cognizant to enhance its iUGO Care software deployments. This partnership aims to leverage Cognizant’s extensive resources and experience in healthcare, allowing Reliq to rapidly extend its Care Management services to large-scale clients. Reliq anticipates maintaining its profit margins while accelerating the deployment process. The collaboration opens new opportunities for Reliq's virtual care solutions in both the US and global markets, thereby addressing the needs of larger patient populations.
Reliq Health Technologies Inc. (OTC:RQHTF) has announced the signing of contracts with four new US clients, including physician practices and a long-term care facility. The addition of these clients will introduce over 3,000 patients to Reliq's platform, projected to generate an average revenue of over $50 per patient monthly. Onboarding is set for early 2022, contributing to a revenue run rate expectation of $2 million per month by year-end 2021. This expansion demonstrates Reliq's growth in the healthcare technology sector.
Reliq Health Technologies Inc. (OTCQB:RQHTF) reported significant growth in Q1 FY2022, with revenues of $1,608,168, up 192% from the previous quarter. Gross margin reached 72% with adjusted EBITDA at $74,126, improving from a loss of $1,518,925 in Q1 FY2021. The company signed contracts with multiple healthcare providers, expanding its iUGO Care platform. Reliq also raised its revenue guidance for CY 2022 to $40 Million CAD due to increased demand.
Reliq Health Technologies Inc. (OTC:RQHTF) has announced contracts with two new clients, adding over 1,000 Medicare patients to its iUGO platform, generating an average revenue of $65 USD per patient per month. The company has also expanded its iUGO Hospice solution, which supports remote monitoring and care for hospice patients. This development is significant given that over 1.5 million Medicare patients were enrolled in hospice care in 2020, indicating a growing demand for their services.
Reliq Health Technologies Inc. (OTC:RQHTF) announced a webinar scheduled for November 30, 2021, to discuss its Q1 Fiscal Year 2022 financial results and provide a corporate update. CEO Dr. Lisa Crossley stated the company is on track to achieve a $2 million/month revenue run rate by year-end 2021, with gross margins of 75% and EBITDA margins of 45%. The company anticipates significant quarter-over-quarter growth through 2022 as Medicare and Medicaid expand virtual care reimbursement.
FAQ
What is the current stock price of RELIQ HEALTH TECHS (RQHTF)?
What is the market cap of RELIQ HEALTH TECHS (RQHTF)?
What is Reliq Health Technologies Inc. known for?
What is the core business of Reliq Health Technologies Inc.?
Who is the current Interim CEO of Reliq Health Technologies Inc.?
How does Reliq Health Technologies Inc. contribute to improving patient outcomes?
What sets Reliq Health Technologies Inc. apart in the digital health industry?
How can investors get in touch with the Investor Relations team at Reliq Health Technologies Inc.?
What are some recent achievements of Reliq Health Technologies Inc.?
What is the goal of Reliq Health Technologies Inc.?
Who can benefit from the solutions offered by Reliq Health Technologies Inc.?
How does Reliq Health Technologies Inc. aim to reduce healthcare costs?